JP2013514811A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514811A5
JP2013514811A5 JP2012546131A JP2012546131A JP2013514811A5 JP 2013514811 A5 JP2013514811 A5 JP 2013514811A5 JP 2012546131 A JP2012546131 A JP 2012546131A JP 2012546131 A JP2012546131 A JP 2012546131A JP 2013514811 A5 JP2013514811 A5 JP 2013514811A5
Authority
JP
Japan
Prior art keywords
bmp
variant
cell
item
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012546131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013514811A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061437 external-priority patent/WO2011087768A1/en
Publication of JP2013514811A publication Critical patent/JP2013514811A/ja
Publication of JP2013514811A5 publication Critical patent/JP2013514811A5/ja
Pending legal-status Critical Current

Links

JP2012546131A 2009-12-22 2010-12-21 免疫原性が抑制されたbmp−7変異体 Pending JP2013514811A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28922009P 2009-12-22 2009-12-22
US61/289,220 2009-12-22
PCT/US2010/061437 WO2011087768A1 (en) 2009-12-22 2010-12-21 Bmp-7 variants with reduced immunogenicity

Publications (2)

Publication Number Publication Date
JP2013514811A JP2013514811A (ja) 2013-05-02
JP2013514811A5 true JP2013514811A5 (enExample) 2014-01-09

Family

ID=43735952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546131A Pending JP2013514811A (ja) 2009-12-22 2010-12-21 免疫原性が抑制されたbmp−7変異体

Country Status (7)

Country Link
US (1) US20130190236A1 (enExample)
EP (1) EP2516456A1 (enExample)
JP (1) JP2013514811A (enExample)
CN (1) CN102822197A (enExample)
AU (1) AU2010341565A1 (enExample)
CA (1) CA2785038A1 (enExample)
WO (1) WO2011087768A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6851965B2 (ja) 2014-09-26 2021-03-31 サハイ バートナガール ラジェンドラ 疾患及び障害の治療のためのnfカッパb活性の阻害剤
EP3240563B1 (en) 2014-12-29 2020-12-09 Bioventus LLC Systems and methods for improved delivery of osteoinductive molecules in bone repair
WO2019148140A2 (en) * 2018-01-26 2019-08-01 Wu Joseph C Implantable biomaterials that enhance stem cell survival and function

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
EP0652951B1 (en) 1990-06-15 1999-09-01 Carnegie Institution Of Washington GDF-1and UOG-1 proteins
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US5849686A (en) 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US6506729B1 (en) 1991-03-11 2003-01-14 Curis, Inc. Methods and compositions for the treatment and prevention of Parkinson's disease
US5674844A (en) 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US6949505B1 (en) 1991-03-11 2005-09-27 Curis, Inc. Morphogen-induced dendritic growth
US5656593A (en) 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US6287816B1 (en) 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
KR100259827B1 (ko) 1991-11-04 2000-06-15 브루스 엠. 에이센, 토마스 제이 데스로저 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법
DE69327645T2 (de) 1992-02-12 2000-09-07 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Dna-sequenzen kodierend für neuartige wachstums-/differentierungsfaktoren
AU681362B2 (en) 1992-11-03 1997-08-28 Stryker Corporation OP-3-induced morphogenesis
WO1994015966A1 (en) 1993-01-12 1994-07-21 Johns Hopkins University School Of Medicine Growth differentiation factor-9
EP0690871A4 (en) 1993-01-12 1999-10-20 Univ Johns Hopkins Med GROWTH DIFFERENTIATION FACTOR-5
ES2201076T3 (es) 1993-03-19 2004-03-16 The Johns Hopkins University School Of Medicine Factor-8 de diferenciacion del crecimiento.
EP0698094B1 (en) 1993-05-12 2004-02-04 Genetics Institute, LLC Bmp-11 compositions
JPH09501305A (ja) 1993-05-12 1997-02-10 ジェネティックス・インスティテュート・インコーポレイテッド Bmp−10組成物
WO1995001801A1 (en) 1993-07-09 1995-01-19 The Johns Hopkins University School Of Medicine Growth differentiation factor-6
CA2171546A1 (en) 1993-10-08 1995-04-20 Se-Jin Lee Growth differentiation factor-10
DE4334646C1 (de) 1993-10-12 1994-09-29 Quinting Friedhelm Durchsichtige Analog-Zeituhr
JP3300500B2 (ja) 1993-10-12 2002-07-08 新日本製鐵株式会社 疲労強度、降伏強度および被削性に優れる熱間鍛造用鋼の製造方法
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
ES2255059T3 (es) 1993-12-07 2006-06-16 Genetics Institute, Llc Bmp-12, bmp-13 y composiciones suyas inductoras de tendon.
IL114397A0 (en) 1994-07-01 1995-10-31 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF-beta-family
DK0776337T3 (da) 1994-07-08 2005-12-12 Univ Johns Hopkins Med Vækstdifferentieringsfaktor-11
AU1120295A (en) 1994-11-07 1996-05-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cartilage-derived morphogenetic proteins
US5635372A (en) 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
KR20000064752A (ko) 1996-03-22 2000-11-06 더 제네랄 호스피탈 코포레이션 중추신경계허혈또는외상의발현후폴리펩티드성장인자를투여하는방법
US6498142B1 (en) 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US6958149B2 (en) 1998-10-06 2005-10-25 Stryker Corporation Repair of larynx, trachea, and other fibrocartilaginous tissues
CA2657302A1 (en) 1998-10-07 2000-04-13 Hermann Oppermann Modified tgf-.beta. superfamily proteins
US6677432B1 (en) 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
US6846906B1 (en) 1998-10-07 2005-01-25 Stryker Corporation Modified proteins of the TGF-β superfamily, including morphogenic proteins
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US8154581B2 (en) 2002-10-15 2012-04-10 Revolutionary Concepts, Inc. Audio-video communication system for receiving person at entrance
US8501424B2 (en) * 2003-11-03 2013-08-06 Danisco Us Inc. Cd4+ epitopes of bone morphogenetic proteins
JP2008500816A (ja) * 2004-03-31 2008-01-17 ゼンコー・インコーポレイテッド 改善された性質を有するbmp−7変異体
WO2005113585A2 (en) 2004-05-20 2005-12-01 Acceleron Pharma Inc. Modified tgf-beta superfamily polypeptides
ATE515268T1 (de) 2004-05-25 2011-07-15 Stryker Corp Verwendung von op-1 zur behandlung von knorpeldefekten
US7659250B2 (en) * 2005-12-22 2010-02-09 Centocor, Inc. BMP-7 variant compositions, methods and uses
WO2007087053A2 (en) 2005-12-22 2007-08-02 Centocor, Inc Bmp-7 variant compositions, methods and uses
WO2008051526A2 (en) * 2006-10-23 2008-05-02 Stryker Corporation Bone morphogenetic proteins
EP2222696A1 (en) * 2007-12-21 2010-09-01 Stryker Corporation Bmp mutants with decreased susceptibility to noggin
JPWO2010117047A1 (ja) 2009-04-10 2012-10-18 株式会社ニコン 光学材料、光学素子、及びその製造方法
JP2011211450A (ja) 2010-03-30 2011-10-20 Victor Co Of Japan Ltd 立体映像表示装置、立体映像撮像装置および立体映像表示方法
US9507084B2 (en) 2010-12-03 2016-11-29 Ofs Fitel, Llc Single-mode, bend-compensated, large-mode-area optical fibers designed to accomodate simplified fabrication and tighter bends
US8886307B2 (en) 2012-01-30 2014-11-11 Medtronic, Inc. Adaptive cardiac resynchronization therapy
WO2013183270A1 (ja) 2012-06-07 2013-12-12 旭化成エレクトロニクス株式会社 位置検出装置
US9298469B2 (en) 2012-06-15 2016-03-29 International Business Machines Corporation Management of multiple nested transactions
US9405290B1 (en) 2013-01-17 2016-08-02 Kla-Tencor Corporation Model for optical dispersion of high-K dielectrics including defects
JP6154215B2 (ja) 2013-06-28 2017-06-28 株式会社日立国際電気 半導体装置の製造方法、基板処理装置およびプログラム
US9170581B2 (en) 2013-09-30 2015-10-27 Crown Equipment Limited Industrial vehicles with overhead light based localization
JP6541301B2 (ja) 2014-03-28 2019-07-10 キヤノン株式会社 ロボット装置、ロボット装置の制御方法、ロボット制御プログラム、及び記録媒体
US9411440B2 (en) 2014-08-22 2016-08-09 Qualcomm Incorporated Digital ultrasonic emitting base station
US9407762B2 (en) 2014-10-10 2016-08-02 Bank Of America Corporation Providing enhanced user authentication functionalities
US9412814B2 (en) 2014-12-24 2016-08-09 Taiwan Semiconductor Manufacturing Co., Ltd. Structure and formation method of FinFET device
US9400685B1 (en) 2015-01-30 2016-07-26 Huawei Technologies Co., Ltd. Dividing, scheduling, and parallel processing compiled sub-tasks on an asynchronous multi-core processor

Similar Documents

Publication Publication Date Title
JP2020507347A5 (enExample)
EP2470559A4 (en) COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING THEM
EA200800368A1 (ru) Гликозилированный il-7, получение и применение
MY188897A (en) Factor viii compositions and methods of making and using same
SA522433360B1 (ar) L-أَسْباراجيناز مُعدل
WO2006119987A3 (en) Recombinant n-glycosylated proteins from procaryotic cells
MX2012015142A (es) Polipeptidos que tiene actividad beta-glucosidasa y usos del mismo.
JP2011528332A5 (enExample)
MX2009008118A (es) Polipeptido e2 del virus del papiloma usado para vacunacion.
JP2009508471A5 (enExample)
JP2015504675A5 (enExample)
JP2020522259A5 (enExample)
JPWO2019156137A5 (enExample)
JP2020172505A5 (enExample)
JP2014529399A5 (enExample)
JP2013514811A5 (enExample)
MY167485A (en) Recombinant human interferon-like proteins
JP2017503505A5 (enExample)
CN108424915A (zh) 犬干扰素-α2重组蛋白的制备方法
MX2022007546A (es) Interferon-alfa-2 modificado que tiene inmunogenicidad reducida.
EA201300059A1 (ru) Полипептид, обладающий активностью сволленина, и его применение
RU2007103735A (ru) Детоксифизим с активностью преобразования афлатоксина и ген, кодирующий детоксифизим
EP4282490A3 (en) Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy
CN101463089A (zh) 人血清白蛋白-干扰素融合蛋白及其编码基因与应用
JP2009507474A5 (enExample)